Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors + Sodium-glucose transport proteins (SGLT2) inhibitors & Type 2 Diabetes (T2D),
CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors + Sodium-glucose transport proteins (SGLT2) inhibitors are oral drugs. They are used for type 2 diabetes (T2D). These drugs can be combined safely and are effective together. Usually, they are added to existing therapy (e.g., metformin). This is for patients who haven't met glycemic targets.
CD26 (Dipeptidyl peptidase 4) (DPP4) inhibitors boost [insulin secretion](brain://WV-Mgea0qUijYEkOlPU_iw/Insulin…